Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $1.7 million.

  • Arcadia Biosciences' Other Non Operating Income rose 1122000.0% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 136222.22%. This contributed to the annual value of $31000.0 for FY2024, which is 3541.67% down from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Other Non Operating Income is $1.7 million, which was up 1122000.0% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Arcadia Biosciences' Other Non Operating Income peaked at $7.5 million during Q1 2021, and registered a low of -$137000.0 during Q4 2024.
  • For the 5-year period, Arcadia Biosciences' Other Non Operating Income averaged around $720666.7, with its median value being $14500.0 (2022).
  • Per our database at Business Quant, Arcadia Biosciences' Other Non Operating Income crashed by 124166.67% in 2024 and then skyrocketed by 1122000.0% in 2025.
  • Over the past 5 years, Arcadia Biosciences' Other Non Operating Income (Quarter) stood at -$100000.0 in 2021, then surged by 96.0% to -$4000.0 in 2022, then surged by 400.0% to $12000.0 in 2023, then tumbled by 1241.67% to -$137000.0 in 2024, then surged by 1339.42% to $1.7 million in 2025.
  • Its Other Non Operating Income was $1.7 million in Q3 2025, compared to $1.1 million in Q2 2025 and -$137000.0 in Q4 2024.